← Back to Screener
ImageneBio, Inc. Common Stock (IMA)
Price$5.65
Growth ScoreF
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-26.04%
Price vs S&P 500 (4W)6.81%
VGM Score20.42
Market Capitalization$66.73M
All Metrics
Book Value / Share (Quarterly)$10.93
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-62.86%
Cash Flow / Share (Quarterly)$-4.62
Price vs S&P 500 (YTD)-26.27%
Net Profit Margin (TTM)-744.28%
EPS (TTM)$-5.40
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-5.40
Revenue Growth (5Y)-38.63%
EPS (Annual)$-9.31
ROI (Annual)-34.06%
Net Profit Margin (5Y Avg)-1488.95%
Cash / Share (Quarterly)$10.39
ROA (Last FY)-29.64%
EBITD / Share (TTM)$-6.99
ROE (5Y Avg)-35.30%
Operating Margin (TTM)-823.43%
Cash Flow / Share (Annual)$-4.28
P/B Ratio0.54x
P/B Ratio (Quarterly)0.43x
Net Income / Employee (Annual)$-3,023,300
ROA (TTM)-31.26%
EPS Incl Extra (Annual)$-9.31
Current Ratio (Annual)12.49x
Quick Ratio (Quarterly)17.67x
3-Month Avg Trading Volume0.26M
52-Week Price Return-63.78%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)83.41x
Asset Turnover (Annual)0.01x
52-Week High$18.00
Operating Margin (5Y Avg)-1585.64%
EPS Excl Extra (Annual)$-9.31
26-Week Price Return-18.12%
Quick Ratio (Annual)12.16x
13-Week Price Return-6.46%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)18.39x
Enterprise Value$-9.32M
Revenue / Share Growth (5Y)-9.18%
Asset Turnover (TTM)0.05x
Revenue / Employee (Annual)$53,300
Pretax Margin (Annual)-5712.37%
Cash / Share (Annual)$12.10
3-Month Return Std Dev72.58%
Net Income / Employee (TTM)$-3,004,900
ROE (Last FY)-34.06%
EPS Basic Excl Extra (Annual)$-9.31
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.40
ROI (TTM)-35.20%
P/S Ratio (TTM)7.29x
Pretax Margin (5Y Avg)-1498.06%
Revenue / Share (Annual)$0.16
Price vs S&P 500 (52W)-88.15%
Year-to-Date Return-18.12%
5-Day Price Return3.29%
EPS Normalized (Annual)$-9.31
ROA (5Y Avg)-30.72%
Net Profit Margin (Annual)-5668.62%
Month-to-Date Return-3.91%
EBITD / Share (Annual)$-9.87
Operating Margin (Annual)-6056.37%
ROI (5Y Avg)-35.30%
EPS Basic Excl Extra (TTM)$-5.40
P/B Ratio (Annual)0.61x
Pretax Margin (TTM)-746.05%
Book Value / Share (Annual)$11.91
Price vs S&P 500 (13W)-14.71%
Beta0.76x
P/FCF (Annual)1.40x
Revenue / Share (TTM)$0.00
ROE (TTM)-35.20%
52-Week Low$3.94
gGradeF
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.95est. -0.71
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.86
3.86
3.86
3.86
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IMAImageneBio, Inc. Common Stock | — | F | D | $5.65 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
ImageneBio is a clinical-stage biopharmaceutical company developing treatments for immunological and inflammatory diseases. Its lead candidate, IMG-007, is a non-depleting anti-OX40 monoclonal antibody being evaluated for atopic dermatitis.